Zacks.com on MSN23h
TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat EstimatesTeva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback